日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

一项针对既往接受过治疗的非小细胞肺癌或初治、不适合顺铂治疗的尿路上皮癌患者的阿维鲁单抗联合阿昔替尼的II期开放标签试验。

Galffy, G; Lugowska, I; Poddubskaya, E V; Cho, B C; Ahn, M-J; Han, J-Y; Su, W-C; Hauke, R J; Dyar, S H; Lee, D H; Serwatowski, P; Estelles, D L; Holden, V R; Kim, Y J; Vladimirov, V; Horvath, Z; Ghose, A; Goldman, A; di Pietro, A; Wang, J; Murphy, D A; Alhadab, A; Laskov, M

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

安奈妥单抗拉坦辛与长春瑞滨治疗复发性间皮素阳性恶性胸膜间皮瘤(ARCS-M)患者的疗效比较:一项随机、开放标签的II期试验

Kindler, Hedy L; Novello, Silvia; Bearz, Alessandra; Ceresoli, Giovanni L; Aerts, Joachim G J V; Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabrò, Luana; Burgers, Jacobus A; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; Van Meerbeeck, Jan P; Nowak, Anna K; Blumenschein, George Jr; Siegel, Jonathan M; Kasten, Linda; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Hassan, Raffit; Fennell, Dean A

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma

程序性死亡配体1基因拷贝数变异和单核苷酸多态性、程序性死亡配体1蛋白表达以及治疗方案对一大群非小细胞肺癌白种人患者总生存期的影响

Grenda, Anna; Krawczyk, Paweł; Kucharczyk, Tomasz; Błach, Justyna; Reszka, Katarzyna; Chmielewska, Izabela; Buczkowski, Jarosław; Kieszko, Robert; Siwiec, Jan; Kubiatowski, Tomasz; Bożyk, Aleksandra; Krukowska, Kinga; Jarosz, Bożena; Paśnik, Iwona; Pankowski, Juliusz; Świniuch, Daria; Stencel, Katarzyna; Gil, Michał; Lew, Kinga; Ramlau, Rodryg; Szczęsna, Aleksandra; Fidler, Sebastian; Sieracki, Andrzej; Każarnowicz, Andrzej; Serwatowski, Piotr; Grodzki, Tomasz; Milanowski, Janusz

Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study

阿法替尼治疗局部晚期/转移性非小细胞肺癌(携带常见EGFR突变),化疗后疗效:一项IV期研究

Thongprasert, Sumitra; Geater, Sarayut L; Clement, Dana; Abdelaziz, Amr; Reyes-Igama, Jasmin; Jovanovic, Dragana; Alexandru, Aurelia; Schenker, Michael; Sriuranpong, Virote; Serwatowski, Piotr; Suresh, Sheethal; Cseh, Agnieszka; Gaafar, Rabab